leflunomide and trimethoprim, sulfamethoxazole drug combination

leflunomide has been researched along with trimethoprim, sulfamethoxazole drug combination in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kallenberg, CG; Stegeman, CA; Tervaert, JW	1
Reinhold-Keller, E	1
Dábague Guzmán, J; Pedroza Granados, J; Zúñiga Varga, J	1
Alfaro-Lozano, JL; Elera-Fitzcarrald, C; Pastor-Asurza, CA	1

Reviews

2 review(s) available for leflunomide and trimethoprim, sulfamethoxazole drug combination

Article	Year
Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis. Current opinion in nephrology and hypertension, 2001, Volume: 10, Issue:2 Topics: Antibodies, Antineutrophil Cytoplasmic; Antilymphocyte Serum; Cyclophosphamide; Guanidines; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Isoxazoles; Kidney Diseases; Leflunomide; Methotrexate; Mycophenolic Acid; Prednisone; Remission Induction; Trimethoprim, Sulfamethoxazole Drug Combination; Tumor Necrosis Factor-alpha; Vasculitis	2001
[Maintainance treatment of anti-neutrophil cytoplasm associated antibodies (ANCA)]. Reumatologia clinica, 2011, Volume: 7 Suppl 3 Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Early Diagnosis; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Induction Chemotherapy; Isoxazoles; Leflunomide; Maintenance Chemotherapy; Methotrexate; Randomized Controlled Trials as Topic; Rituximab; Severity of Illness Index; Trimethoprim, Sulfamethoxazole Drug Combination	2011

Article

Year

Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis.

Current opinion in nephrology and hypertension, 2001, Volume: 10, Issue:2

Topics: Antibodies, Antineutrophil Cytoplasmic; Antilymphocyte Serum; Cyclophosphamide; Guanidines; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Isoxazoles; Kidney Diseases; Leflunomide; Methotrexate; Mycophenolic Acid; Prednisone; Remission Induction; Trimethoprim, Sulfamethoxazole Drug Combination; Tumor Necrosis Factor-alpha; Vasculitis

2001

[Maintainance treatment of anti-neutrophil cytoplasm associated antibodies (ANCA)].

Reumatologia clinica, 2011, Volume: 7 Suppl 3

Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Early Diagnosis; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Induction Chemotherapy; Isoxazoles; Leflunomide; Maintenance Chemotherapy; Methotrexate; Randomized Controlled Trials as Topic; Rituximab; Severity of Illness Index; Trimethoprim, Sulfamethoxazole Drug Combination

2011

Other Studies

2 other study(ies) available for leflunomide and trimethoprim, sulfamethoxazole drug combination

Article	Year
[How long should cyclophosphamide therapy of Wegener's granulomatosis continue?]. Deutsche medizinische Wochenschrift (1946), 2002, Sep-13, Volume: 127, Issue:37 Topics: Adjuvants, Immunologic; Administration, Oral; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Controlled Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Follow-Up Studies; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Prednisolone; Prognosis; Remission Induction; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination	2002
Garre's sclerosing osteomyelitis caused by salmonella group D in a patient with systemic lupus erythematosus: an unusual complication. Clinical rheumatology, 2015, Volume: 34, Issue:12 Topics: Adult; Anti-Bacterial Agents; Antiphospholipid Syndrome; Ceftazidime; Doxycycline; Femur; Humans; Hydroxychloroquine; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Male; Methotrexate; Osteomyelitis; Prednisone; Salmonella Infections; Sclerosis; Trimethoprim, Sulfamethoxazole Drug Combination	2015

Article

Year

[How long should cyclophosphamide therapy of Wegener's granulomatosis continue?].

Deutsche medizinische Wochenschrift (1946), 2002, Sep-13, Volume: 127, Issue:37

Topics: Adjuvants, Immunologic; Administration, Oral; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Controlled Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Follow-Up Studies; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Prednisolone; Prognosis; Remission Induction; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination

2002

Garre's sclerosing osteomyelitis caused by salmonella group D in a patient with systemic lupus erythematosus: an unusual complication.

Clinical rheumatology, 2015, Volume: 34, Issue:12

Topics: Adult; Anti-Bacterial Agents; Antiphospholipid Syndrome; Ceftazidime; Doxycycline; Femur; Humans; Hydroxychloroquine; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Male; Methotrexate; Osteomyelitis; Prednisone; Salmonella Infections; Sclerosis; Trimethoprim, Sulfamethoxazole Drug Combination

2015